ASK REDCHAT ANYTHING ABOUT UNIQURE N.V.
uniQure N.V. (NASDAQ: QURE)
Listen to this Section
$42.61
-0.0200
(
-0.05% )
0.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| HEMGENIX® (etranacogene dezaparvovec-drlb) (AMT-061)DetailsHemophilia, Rare diseases, Rare genetic disease |
Approved |
| AMT-191DetailsFabry disease, Genetic disorder |
Phase 1/2 |
| AMT-130DetailsHuntington's disease, Genetic disorder |
Phase 1/2 |
| AMT-260DetailsEpilepsy, Mesial temporal lobe epilepsy |
Phase 1/2 |
| AMT-162DetailsAmyotrophic lateral sclerosis |
Phase 1/2 |
Market Data
|
| Open |
$42.61 |
| Previous Close |
$42.63 |
| Volume |
0.1K |
| Market Cap |
$2.93B |
| Day Range |
$42.57 - $43.28 |
| 52 Week Range |
$8.73 - $71.50 |
| Shares Outstanding |
68.75M |
| Change % |
-0.05% |
| Net Change |
▼ -0.0200 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2014 |
| Country | Netherlands |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-477,017.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-03-05 |
Sale |
-33000.00 |
CALOZ PIERRE |
| 2024-03-05 |
Sale |
-49500.00 |
Abi-Saab Walid |
| 2024-03-05 |
Sale |
-49500.00 |
KLEMT CHRISTIAN |
| 2024-03-05 |
Sale |
-150000.00 |
Kapusta Matthew C |
| 2024-02-28 |
Sale |
-9455.00 |
CALOZ PIERRE |
| 2024-02-28 |
Sale |
-15906.00 |
KLEMT CHRISTIAN |
| 2024-02-28 |
Sale |
-27904.00 |
Kapusta Matthew C |
| 2023-09-20 |
Sale |
-5841.00 |
Dolmetsch Ricardo |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
1 |
Nov 14, 2025 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| 10-q |
Quarterly Reports |
77 |
Nov 10, 2025 |
| 4 |
Insider transactions |
1 |
Nov 10, 2025 |
| 8-k |
8K-related |
14 |
Nov 10, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 8-k |
8K-related |
14 |
Nov 03, 2025 |
| 8-k |
8K-related |
21 |
Sep 29, 2025 |
| 4 |
Insider transactions |
1 |
Sep 26, 2025 |
| 4 |
Insider transactions |
1 |
Sep 26, 2025 |